Healthcare Industry News: radiosurgery
News Release - April 20, 2016
John Lapré to Fulfill Role as Elekta’s Chief Technology OfficerSTOCKHOLM--(Healthcare Sales & Marketing Network)--In order to further strengthen its innovation leadership, Elekta (EKTA-B.ST) announced today the appointment of John Lapré as Chief Technology Officer, effective May 1, 2016.
John Lapré says: “The CTO responsibilities are to stimulate growth through innovation and to further raise customer satisfaction with the clinical effectiveness of Elekta’s portfolio.”
Tomas Puusepp, President and CEO, says the role demonstrates the company’s continued commitment to advancing health care and improving outcomes for patients. He says: “John Lapré will be an ideal CTO. In addition to intimately knowing the company and our industry, he has a keen understanding of collaboration and innovation, which are key elements for our customers and their patients.”
John Lapré previously held the title of Executive Vice President Research and Innovation at Elekta. Prior to this, he was Executive Vice President Brachytherapy and before joining Elekta in 2011, John was Vice President R&D at Nucletron.
John Lapré received his MSc and PhD in Toxicology & Nutrition in the Netherlands, majoring in intestinal physiology, toxicology and biochemistry. His PhD focused on the prevention of colorectal cancer.
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on April 20, 2016.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.